Drugs / HPDC-T cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT02615639 | Nov 2015 → Nov 2018 | chronic hepatitis B virus infection | Third Affiliated Hospital, Sun Yat-Sen University | Unknown | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HPDC-T cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02615639 ↗ |
| Known as | Hepatitis B Vaccine activated-DCs | “Hepatitis B Vaccine activated-DCs (HPDC-T cells)” NCT02615639 ↗ |
| Modality | Cell therapy | “Hepatitis B Vaccine activated-DCs (HPDC-T cells)” NCT02615639 ↗ |
| Route | Intravenous | “HPDC-T cells 1-5×10\^5 intravenous injection” NCT02615639 ↗ |